These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2819393)

  • 1. DNA ploidy and the prognosis of stage pT1 bladder cancer.
    Masters JR; Camplejohn RS; Parkinson MC; Woodhouse CR
    Br J Urol; 1989 Oct; 64(4):403-8. PubMed ID: 2819393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
    Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
    Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.
    Thomas DJ; Robinson MC; Charlton R; Wilkinson S; Shenton BK; Neal DE
    Br J Urol; 1994 May; 73(5):533-7. PubMed ID: 8012776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
    al-Abadi H; Nagel R
    J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of flow cytometry in superficial bladder cancer.
    Di Silverio F; von Heland M; De Berardinis E; Izzi R; Buscarini M; De Vita R; Forte R; Seccareccia F; Menotti A
    Eur Urol; 1992; 21 Suppl 1():22-5. PubMed ID: 1425833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
    Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
    J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA profile and tumour progression in patients with superficial bladder tumours.
    Gustafson H; Tribukait B; Esposti PL
    Urol Res; 1982 Feb; 10(1):13-8. PubMed ID: 7072022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
    Tribukait B; Gustafson H; Esposti PL
    Br J Urol; 1982 Apr; 54(2):130-5. PubMed ID: 7082931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
    Lee SE; Park MS
    Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.